A Lentivirus infectious disease that results_in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_agent Human immunodeficiency virus 1 or has_agent Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has_symptom diarrhea, has_symptom fatigue, has_symptom fever, has_symptom vaginal yeast infection, has_symptom headache, has_symptom mouth sores, has_symptom muscle aches, has_symptom sore throat, and has_symptom swollen lymph glands.
- Aliases
- [X]Human immunodeficiency virus disease
- [X]Human immunodeficiency virus disease (disorder)
- [X]Unspecified human immunodeficiency virus [HIV] disease
- [X]Unspecified human immunodeficiency virus [HIV] disease (disorder)
- HIV - Human immunodeficiency virus infection
- HIV INFECT
- HIV Infection
- HIV infection
- HIV Infections
- HIV infectious disease
- HTLV III INFECT
- HTLV III Infections
- HTLV III LAV INFECT
- HTLV III LAV Infections
- HTLV WIII INFECTIONS
- HTLV WIII LAV INFECTIONS
- HTLV-III Infection
- HTLV-III Infections
- HTLV-III-LAV Infection
- HTLV-III-LAV Infections
- HUMAN IMMUNO VIRUS DIS
- human immunodeficiency virus
- Human immunodeficiency virus [HIV] disease
- HUMAN IMMUNOdeficiency VIRUS [HIV] INFECTION
- Human immunodeficiency virus caused disease or disorder
- Human immunodeficiency virus disease
- Human immunodeficiency virus disease (disorder)
- Human immunodeficiency virus disease or disorder
- Human immunodeficiency virus infection
- Human immunodeficiency virus infection (disorder)
- Human immunodeficiency virus infection, NOS
- Human immunodeficiency virus infectious disease
- human immunodeficiency virus infectious disease
- Infection, HIV
- Infection, HTLV-III
- Infection, HTLV-III-LAV
- Infections, HIV
- Infections, HTLV-III
- Infections, HTLV-III-LAV
- LYMPHOTROPIC VIRUS TYPE III INFECTIONS HUMAN T
- T LYMPHOTROPIC VIRUS TYPE III INFECT HUMAN
- T Lymphotropic Virus Type III Infections, Human
- T-Lymphotropic Virus Type III Infections, Human
- Unspecified human immunodeficiency virus [HIV] disease (disorder)
- Studies related to HIV infection Advanced search
| Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon |
| Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals |
| Antenatal gut microbiome profiles and effect on pregnancy outcome in HIV infected and HIV uninfected women in a resource limited setting |
| Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging |
| Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance |
| Alterations in the gut microbiota of patients with acquired immune deficiency syndrome |
| Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population |
| HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota |
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia |
| Relationship between the Cervical Microbiome, HIV Status, and Precancerous Lesions |
| Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria |
| Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men |
| Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy |
| Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation |
| Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection |
| Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial |
| Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals |
| Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART |
| Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study |
| High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy |
| HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases |
| Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function |
| Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy |
| Evolution of the gut microbiome following acute HIV-1 infection |
| Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation |
| Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation |
| The semen microbiome and its relationship with local immunology and viral load in HIV infection |
| Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection |
| Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients |
